transcriptomics
Agendia Building Validation Data on ImPrint for Guiding Neoadjuvant Immunotherapy in Breast Cancer
Premium
The firm envisions marketing the 53-gene signature with its existing MammaPrint and BluePrint tests as a comprehensive platform for breast cancer treatment selection.
The lead investigators have also spun out a company, Isabl, aiming to make the approach available to the broader community.
Cancer Genomics Project in Southwestern American Indians Aims to Improve Research, Care Disparities
The NCI-funded project, which was delayed due to the pandemic, is poised to begin, and aims to provide actionable data and build a reference genome for American Indians.
The Israeli firm's ENLIGHT test uses transcriptome sequencing plus functional drug interaction data to match more patients to drugs compared to current methods.
Zentalis Pharmaceuticals, Caris Life Sciences Ink Precision Oncology Partnership
Caris will use its platform to sequence solid tumor patients' full exomes and transcriptomes to determine eligibility for Zentalis' Wee1 inhibitor ZN-c3.